These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9272279)

  • 1. Serum complement activation of SLE patients during plasmapheresis.
    Csipö I; Kávai M; Kiss E; Bedö Z; Csongor J; Szegedi G; Philbert F; Cohen JH
    Autoimmunity; 1997; 25(3):139-46. PubMed ID: 9272279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE).
    Csípö I; Kiss E; Soltész P; Antal-Szalmás P; Szegedi G; Cohen JH; Taylor RP; Kávai M
    Clin Exp Immunol; 1999 Dec; 118(3):458-64. PubMed ID: 10594568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complex clearance by complement receptor type 1 in SLE.
    Kavai M
    Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal variations in complement activation and deposition of C3b and C4b on model immune complexes.
    Yokoyama I; Waxman F
    Immunology; 1993 Oct; 80(2):168-76. PubMed ID: 8262546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
    Arvieux J; Yssel H; Colomb MG
    Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes.
    Kávai M; Rasmussen JM; Baatrup G; Zsindely A; Svehag SE
    Scand J Immunol; 1988 Jul; 28(1):123-8. PubMed ID: 2969612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
    Lucisano Valim YM; Lachmann PJ
    Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.
    Birmingham DJ; Chen W; Liang G; Schmitt HC; Gavit K; Nagaraja HN
    Immunology; 2003 Apr; 108(4):531-8. PubMed ID: 12667215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Hammond A; Rudge AC; Loizou S; Bowcock SJ; Walport MJ
    Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
    Kalunian KC; Chatham WW; Massarotti EM; Reyes-Thomas J; Harris C; Furie RA; Chitkara P; Putterman C; Gross RL; Somers EC; Kirou KA; Ramsey-Goldman R; Hsieh C; Buyon JP; Dervieux T; Weinstein A
    Arthritis Rheum; 2012 Dec; 64(12):4040-7. PubMed ID: 22932861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding to erythrocyte complement receptor type 1 of BSA/anti-BSA complexes opsonized by C4A3 or C4B1 in the presence of serum.
    Klint C; Truedsson L; Sturfelt G
    Scand J Immunol; 1995 Oct; 42(4):425-32. PubMed ID: 7569775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
    Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
    APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.
    Birmingham DJ; Irshaid F; Gavit KF; Nagaraja HN; Yu CY; Rovin BH; Hebert LA
    Mol Immunol; 2007 Jul; 44(14):3510-6. PubMed ID: 17467802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of C3b receptor (CR1) on erythrocytes of patients with systemic lupus erythematosus contrasts with its normal expression in other systemic diseases and does not correlate with the occurrence or severity of SLE nephritis.
    Jouvin MH; Wilson JG; Bourgeois P; Fearon DT; Kazatchkine MD
    Complement; 1986; 3(2):88-96. PubMed ID: 2945697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
    Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
    Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
    Wilson JG; Ratnoff WD; Schur PH; Fearon DT
    Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.